Compare Mutual Funds

Pros

-

5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

Cons

-

-

INDMoney rank
-
-
Category

Equity, Index Funds

Equity, Index Funds

Fund Age

3 Years 3 Months

5 Years 1 Months

Fund AUM

₹97 Cr

₹8712 Cr

Min Investment
  1. SIP ₹1000
  2. Lumpsum ₹1000
  1. SIP ₹500
  2. Lumpsum ₹1000
Expense Ratio

0.37%

0.43%

Exit Load

0%

0%

Benchmark Index

Nifty Pharma TR INR

Nifty200 Momentum 30 TR INR

No of Holdings

22

32

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(21.81%)
  2. Divi's Laboratories Ltd(9.65%)
  3. Dr Reddy's Laboratories Ltd(9.29%)
  4. Cipla Ltd(8.99%)
  5. Lupin Ltd(6.62%)
  1. State Bank of India(6.1%)
  2. Shriram Finance Ltd(5.51%)
  3. Eicher Motors Ltd(5.36%)
  4. Hindalco Industries Ltd(5.19%)
  5. Bajaj Finance Ltd(4.88%)
No of Sectors

1

8

Top 3 Sectors

Health

(100%)

  1. Corporate(71.85%)
  2. Financial Services(47.19%)
  3. Consumer Cyclical(20.44%)
Equity %

99.35%

99.94%

Debt %

-

-

P/E

32.91

25.38

P/B

4.7

4.04

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

-1.67%

-9.55%

3-Month Return

-0.26%

-8.54%

6-Month Return

3.2%

-5.37%

1-Year Return

5.54%

1.59%

3-Year Return

24.27%

17.76%

5-Year Return

-

15.43%

Sharpe

1.04

0.83

Alpha

-0.87

-0.27

Beta

1

1

Standard Deviation

16.54

17.35

Information Ratio

-4.16

-1.5

Description

ICICI Prudential Nifty Pharma Index Fund is an equity fund.The fund could potentially beat inflation in the long-run.

UTI Nifty200 Momentum 30 Index Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Ashwini Shinde, Nishit Patel

Ayush Jain, Sharwan Kumar Goyal

Most Popular Comparisons